Role of Type I IFN Signaling in Seoul Orthohantavirus Pathogenesis
I 型干扰素信号传导在首尔正汉坦病毒发病机制中的作用
基本信息
- 批准号:10513504
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-19 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:Adherens JunctionAntiviral ResponseAsiaAutomobile DrivingBindingBiomedical ResearchBloodBlood VesselsCardiopulmonaryCase Fatality RatesCell physiologyCellsCoagulation ProcessConnexinsConsequentialismDataDiseaseDisease OutcomeEndothelial CellsEndothelial Growth Factors ReceptorEndotheliumEtiologyExtravasationFamilyGene ExpressionGeneticGenomicsHantaan virusHantavirusHantavirus InfectionsHemorrhagic Fever with Renal SyndromeHumanImmuneImmune signalingImmunologicsImmunologyIn VitroInfectionInflammationInflammatoryInhalationInterferon ActivationInterferon Type IInterferonsInvestigationKidneyLaboratory RatLeadLeukocytesLiteratureLocationLungMediatingModelingMolecularNatural ImmunityNeutrophil ActivationNeutrophil InfiltrationOutcomePathogenesisPathogenicityPathway AnalysisPathway interactionsPatternPermeabilityPlatelet ActivationPublishingRNARNA VirusesRattusRattus norvegicusRegulationRegulatory T-LymphocyteResourcesRodentRoleSeoul virusSignal PathwaySignal TransductionSiteSourceStimulusSyndromeTestingTherapeuticTissue-Specific Gene ExpressionTissuesTranscriptional ActivationVascular DiseasesVascular Endothelial Growth FactorsViralViral Hemorrhagic FeversVirus DiseasesVirus ReplicationWorkZoonosesantagonistcell motilitychemokinechronic infectioncomparativecytokinehuman diseaseimmune activationin vivoinfected vector rodentinnate immune mechanismsmigrationneutrophilnovelpathogenpreservationreceptorrecruitresponsetooltranscriptomicsvascular inflammationviral detectionvirus host interactionwound healing
项目摘要
PROJECT SUMMARY
Hantaviruses are a family of zoonotic RNA viruses found in insectivore and rodent hosts worldwide. The Old
World hantaviruses, Hantaan virus (HTNV) and Seoul virus (SEOV), are the etiologic agents of hemorrhagic
fever with renal syndrome (HFRS), the most common hemorrhagic fever disease in Asia. Hantaviruses primarily
target endothelial cells for infection and drive vascular leakage and dysregulation, through poorly defined means.
In their respective reservoir hosts, hantaviruses establish asymptomatic, persistent infections. The mechanisms
underlying these divergent infection outcomes remain unknown and no therapeutic exists to treat HFRS. Our
previously published data demonstrates that type I interferon (IFN) effectively limits HTNV replication and that
the cytoplasmic RNA recognition receptors RIG-I and MDA5 are required for initiating the type I IFN response in
human endothelial cells during hantavirus infection. Here we show that, in contrast, SEOV infection in its natural
reservoir host does not result in innate immune transcriptional activation in vitro and, more interestingly, IFNβ
treatment does not limit SEOV replication in reservoir cells. Further, global transcriptomic analysis of human and
rat endothelial cells infected with SEOV reveal striking, host-specific patterns of differential gene expression for
the IFN and leukocyte extravasation pathways. Predicted network analysis identified differential regulation of the
vascular endothelial growth factor (VEGF) receptor signaling pathway, with increased gene expression related
to activation and migration in human endothelial cells compared to reservoir endothelial cells. These data, along
with substantial literature in the field demonstrating a significant effect of type I IFN on vascular function, lead us
to hypothesize that type I IFN signaling following SEOV infection in humans drives endothelial cell activation,
vascular dysregulation, and recruitment of proinflammatory neutrophils that are the hallmarks of HFRS. Further,
we hypothesize that the reservoir host for SEOV, the common rat, escapes severe disease through viral-induced
inhibition of type I IFN activation and reduced inflammation. We will test this hypothesis by: 1) dissecting the
virus-host interactions that initiate and antagonize reservoir and non-reservoir innate immunity, 2) investigating
the contribution of type I IFN signaling to vascular dysfunction in SEOV-infected endothelial cells, and 3) defining
the role of type I IFN signaling in neutrophil activation and extravasation across SEOV-infected endothelial cells
from reservoir and human hosts. While similar comparative immunology approaches to understanding
pathogenesis for other zoonotic RNA viruses have been successful, the limited tractability of most reservoir
rodent hosts has significantly limited progress in the hantavirus field. Thus, the intentional selection to study
SEOV and its natural reservoir, the common laboratory rat, provides us with the genomic and immunologic
resources to complete a novel, in depth investigation into the immunopathogenic mechanisms underlying
hantavirus disease in humans.
项目摘要
汉坦病毒是在全球昆虫动物和啮齿动物宿主中发现的人畜共患病毒家族。旧
世界汉坦病毒,汉坦病毒(HTNV)和首尔病毒(SEOV)是出血的病因学药物
肾脏综合征发烧(HFRS),这是亚洲最常见的出血热疾病。汉坦病毒主要
靶向内皮细胞通过较差的平均值,用于感染并驱动血管泄漏和失调。
在各自的储层宿主中,汉坦病毒建立了渐近的持续感染。机制
这些不同的感染结果的基础仍然未知,并且没有治疗HFR的治疗性。我们的
先前发布的数据表明,I型干扰素(IFN)有效地限制了HTNV复制,并且
启动I型IFN响应需要的细胞质RNA识别受体RIG-I和MDA5是必需的
汉坦病毒感染期间人体内皮细胞。在这里,我们表明,相比之下,SEOV自然感染了
储层宿主不会在体外导致先天免疫转录激活,更有趣的是,IFNβ
处理不会限制储层细胞中的SEOV复制。此外,对人类和人类的全球转录组分析
被SEOV感染的大鼠内皮细胞揭示了罢工,降低基因表达的宿主特异性模式
IFN和白细胞渗出途径。预测的网络分析确定了对
血管内皮生长因子(VEGF)受体信号通路,基因表达相关的增加
与储层内皮细胞相比,人内皮细胞的激活和迁移。这些数据,沿着
该领域的大量文献证明了I型IFN对血管功能的显着影响,引导我们
为了假设人类SEOV感染后的I型IFN信号传导驱动内皮细胞激活,
血管失调,并募集促炎性中性粒细胞,这是HFRS的标志。更远,
我们假设普通大鼠的SEOV的储层宿主通过病毒诱导的
抑制I型IFN激活并减少注射。我们将通过:1)剖析此假设
启动和拮抗储层和非储液先天免疫的病毒宿主相互作用,2)研究
I型IFN信号对SEOV感染的内皮细胞中血管功能障碍的贡献,3)定义
I型IFN信号传导在SEOV感染的内皮细胞之间的中性粒细胞激活和渗出中的作用
来自水库和人类托管。而类似的比较免疫学方法来理解
其他人畜共患病毒病毒的发病机理已成功,大多数参考者的障碍性有限
啮齿动物宿主在汉塔病毒场的进展显着有限。那是有意学习的选择
SEOV及其天然储层是普通实验室大鼠,为我们提供了基因组和免疫学
资源完成小说,深入研究对免疫发育机制
人类汉坦病毒病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alison Kell其他文献
Alison Kell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alison Kell', 18)}}的其他基金
Role of Type I IFN Signaling in Seoul Orthohantavirus Pathogenesis
I 型干扰素信号传导在首尔正汉坦病毒发病机制中的作用
- 批准号:
10668522 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
相似国自然基金
基于HEV介导炎症反应与干扰素通路信号交互机制的抗病毒策略研究
- 批准号:82370610
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RNA分子SNORA31结合cGAS并调控小胶质细胞的抗病毒天然免疫反应的作用与机制研究
- 批准号:82301981
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
溶质载体SLC38A10调控抗病毒天然免疫反应的作用及分子机制
- 批准号:32370926
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
豆天蛾质型多角体病毒的分离鉴定及其抑制宿主RNAi抗病毒反应的分子机制
- 批准号:32360701
- 批准年份:2023
- 资助金额:32.00 万元
- 项目类别:地区科学基金项目
精氨酸甲基转移酶PRMT9调控RLRs介导天然免疫抗病毒反应的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Discovery of antiviral inhibitors for the treatment of orthopoxvirus infections
发现治疗正痘病毒感染的抗病毒抑制剂
- 批准号:
10761185 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
IAS 2023,第 12 届 IAS HIV 科学会议,澳大利亚布里斯班,虚拟会议,2023 年 7 月 23-26 日
- 批准号:
10696505 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Role of Type I IFN Signaling in Seoul Orthohantavirus Pathogenesis
I 型干扰素信号传导在首尔正汉坦病毒发病机制中的作用
- 批准号:
10668522 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
SHINING A LIGHT ON BAT CELLULAR IMMUNITY FOLLOWING VIRUS INFECTION
揭示病毒感染后蝙蝠细胞免疫
- 批准号:
10618969 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Reagents to Chemically Tag Specific Coronavirus Spike Proteins
化学标记特定冠状病毒刺突蛋白的试剂
- 批准号:
10259048 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别: